Bohring–Opitz syndrome

Bohring–Opitz syndrome
Other namesOberklaid–Danks syndrome, C-like syndrome
SpecialtyMedical genetics Edit this on Wikidata
Complicationsobstructive apnea, Wilms tumor, lung infections, heart problems
Usual onsetCongenital

Bohring–Opitz syndrome (BOS) is a medical syndrome caused by a mutation in the ASXL1 gene.

Presentation

[edit]

This condition is characterised by craniofacial appearance, fixed contractures of the upper limbs, abnormal posture, feeding difficulties, intellectual disability, small size at birth and failure to thrive.[1]

Children with BOS can also have recurring respiratory infections, silent aspiration, sleep apnea, developmental delay, abnormal hair density and length, Wilms' tumors, brain abnormalities, and other issues.[citation needed]

Genetics

[edit]

Genetically, de novo truncating mutations in ASXL1 have been shown to account for approximately 50% of Bohring–Opitz syndrome cases.[2][3]

A second gene associated with this condition is the Kelch-like family member 7 (KLHL7).[citation needed]

Diagnosis

[edit]

As some of these features are shared with other genetic syndromes, the diagnosis is made by genetic testing.[citation needed]

Epidemiology

[edit]

The syndrome is extremely rare, with fewer than 80 reported cases worldwide.[citation needed]

References

[edit]
  1. ^ Hastings R; Cobben JM; Gillessen-Kaesbach G; et al. (2011). "Bohring–Opitz (Oberklaid–Danks) syndrome: clinical study, review of the literature, and discussion of possible pathogenesis". European Journal of Human Genetics. 19 (5): 513–519. doi:10.1038/ejhg.2010.234. PMC 3083618. PMID 21368916.
  2. ^ Hoischen A; van Bon BW; Rodríguez-Santiago B; et al. (2011). "De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome". Nature Genetics. 43 (8): 729–731. doi:10.1038/ng.868. PMID 21706002. S2CID 10367717.
  3. ^ Magini P; Della Monica M; Uzielli ML; et al. (2012). "Two novel patients with Bohring–Opitz syndrome caused by de novo ASXL1 mutations". American Journal of Medical Genetics Part A. 158A (4): 917–921. doi:10.1002/ajmg.a.35265. PMID 22419483. S2CID 44412661.
[edit]